Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 5,183 | 5,777 | 5,045 | 8,507 | 9,663 |
| Operating Income | -5,183 | -5,777 | -5,045 | -8,507 | -9,663 |
| Other Income | 182 | -99 | 1 | 1 | 11 |
| Pre-tax Income | -5,001 | -5,876 | -5,044 | -8,506 | -9,652 |
| Net Income Continuous | -5,001 | -5,876 | -5,044 | -8,506 | -9,652 |
| Net Income | $-5,001 | $-5,876 | $-5,044 | $-8,506 | $-9,652 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.02 | -0.04 | -0.06 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.02 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.02 | -0.04 | -0.06 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.02 | -0.04 | -0.05 |
| EBITDA(a) | $-5,012 | $-5,606 | $-4,874 | $-8,336 | $-9,492 |